An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials

Eye (Basingstoke)

Volumn 32, Issue 1, 2018, Pages 74-80

  Fleck, B W ^a   Williams, C ^b   Juszczak, E ^c   Cocker, K ^d   Stenson, B J ^e   Darlow, B A ^f   Dai, S ^g   Gole, G A ^h   Quinn, G E ⁱ   Wallace, D K ^j   Ells, A ^k   Carden, S ^l   Butler, L ^m   Clark, D ⁿ   Elder, J ^o,p   Wilson, C ^q   Biswas, S ^r   Shafiq, A ^s   King, A ^c   Brocklehurst, P ^c   Fielder, A R ^t   Cottrell, David G ^u   Altaie, Rasha ^g   Essex, Rohan W ^v   Lam, Geoffrey C ^w   Forrest, Michael ^h   Shah, Shaheen ^x   Smith, James ^y   Smith, Jeremy ^y   Taranath, Deepa ^z   O'Keefe, Michael ^aa   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j DUKE UNIVERSITY   (United States)

^k UNIVERSITY OF CALGARY   (Canada)

^l ROYAL CHILDREN'S HOSPITAL   (Australia)

^m CITY HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^o ROYAL CHILDREN'S HOSPITAL   (Australia)

^p UNIVERSITY OF MELBOURNE   (Australia)

^q CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^r MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^s Newcastle Eye Centre   (United Kingdom)

^t CITY UNIVERSITY   (United Kingdom)

^u ROYAL VICTORIA INFIRMARY   (United Kingdom)

^v AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^w PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^x LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^y CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^z WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^aa CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EYE EXAMINATION; FEMALE; HUMAN; IMAGE QUALITY; INFANT; MALE; OXYGEN SATURATION; PHASE 2 CLINICAL TRIAL; READING; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; VISUAL IMPAIRMENT; AUSTRALIA; CANADA; CLINICAL TRIAL; FOLLOW UP; GESTATIONAL AGE; INCIDENCE; METABOLISM; MULTICENTER STUDY; NEW ZEALAND; NEWBORN; OPHTHALMOSCOPY; OXYGEN CONSUMPTION; OXYGEN THERAPY; PHYSIOLOGY; PREMATURITY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; UNITED KINGDOM; UNITED STATES;

OXYGEN;

AUSTRALIA; CANADA; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEW ZEALAND; OPHTHALMOSCOPY; OXYGEN; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINOPATHY OF PREMATURITY; UNITED KINGDOM; UNITED STATES;

EID: 85040314514     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2017.150     Document Type: Article

References (41)

1. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123(7): 991-999.
2. Darlow BA, Elder MJ, Horwood LJ, Donoghue DA, Henderson-Smart DJ, Australian and New Zealand Neonatal Network. Does observer bias contribute to variations in the rate of retinopathy of prematurity between centres? Clin Exp Ophthalmol 2008; 36(1): 43-46.
3. Chiang MF, Keenan JD, Starren J, Du YE, Schiff WM, Barile GR et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol 2006; 124(3): 322-327.
4. Chiang MF, Starren J, Du YE, Keenan JD, Schiff WM, Barile GR et al. Remote image based retinopathy of prematurity diagnosis: a receiver operating characteristic analysis of accuracy. Br J Ophthalmol 2006; 90(10): 1292-1296.
5. Chiang MF, Jiang L, Gelman R, Du YE, Flynn JT. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 2007; 125(7): 875-880.
6. Scott KE, Kim DY, Wang L, Kane SA, Coki O, Starren J et al. Telemedical diagnosis of retinopathy of prematurity intraphysician agreement between ophthalmoscopic examination and image-based interpretation. Ophthalmology 2008; 115(7): 1222-1228 e3.
7. Wallace DK, Quinn GE, Freedman SF, Chiang MF. Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS 2008; 12(4): 352-356.
8. Williams SL, Wang L, Kane SA, Lee TC, Weissgold DJ, Berrocal AM et al. Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders. Br J Ophthalmol 2010; 94(3): 351-356.
9. Slidsborg C, Forman JL, Fielder AR, Crafoord S, Baggesen K, Bangsgaard R et al. Experts do not agree when to treat retinopathy of prematurity based on plus disease. Br J Ophthalmol 2012; 96(4): 549-553.
10. Gschliesser A, Stifter E, Neumayer T, Moser E, Papp A, Pircher N et al. Inter-expert and intra-expert agreement on the diagnosis and treatment of retinopathy of prematurity. Am J Ophthalmol 2015; 160(3): 553-560 e3.
11. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W et al. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 2011; 11: 6.
12. Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L et al. Group BIUKC, Group BIAC, Group BINZC Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013; 368 (22):2094-2104.
13. Australia B-I, United Kingdom Collaborative G, Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E et al. Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med 2016; 374(8): 749-760.
14. Darlow BA, Marschner SL, Donoghoe M, Battin MR, Broadbent RS, Elder MJ et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr 2014; 165(1): 30-35 e2.
15. Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013; 309(20): 2111-2120.
16. Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012; 367(26): 2495-2504.
17. Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR et al. Network SSGotEKSNNR Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362(21):1959-1969.
18. Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121(12): 1684-1694.
19. Moreton RB, Fleck BW, Fielder AR, Williams CA, Butler L, Wilson C et al. The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial. Eye 2016; 30(4): 577-581.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
21. Thomas K, Shah PS, Canning R, Harrison A, Lee SK, Dow KE. Retinopathy of prematurity: risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinatal Med 2015; 8(3): 207-214.
22. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005; 115(5): e518-e525.
23. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013; 74(Suppl 1): 35-49.
24. Tan Z, Chong C, Darlow B, Dai S. Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review. Br J Ophthalmol 2015; 99(6): 801-806.
25. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314(10): 1039-1051.
26. Dhaliwal C, Fleck B, Wright E, Graham C, McIntosh N. Incidence of retinopathy of prematurity in Lothian, Scotland, from 1990 to 2004. Arch Dis Child Fetal Neonatal ed 2008; 93(6): F422-F426.
27. Phelps DL. It's plus disease, isn't it? Arch Ophthalmol 2007; 125(7): 963-964.
28. Paul Chan RV, Williams SL, Yonekawa Y, Weissgold DJ, Lee TC, Chiang MF. Accuracy of retinopathy of prematurity diagnosis by retinal fellows. Retina 2010; 30(6): 958-965.
29. Myung JS, Paul Chan RV, Espiritu MJ, Williams SL, Granet DB, Lee TC et al. Accuracy of retinopathy of prematurity image-based diagnosis by pediatric ophthalmology fellows: implications for training. J AAPOS 2011; 15(6): 573-578.
30. Walton OBt, Garoon RB, Weng CY, Gross J, Young AK, Camero KA et al. Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol 2016; 134(2): 204-209.
31. Abramoff MD, Folk JC, Han DP, Walker JD, Williams DF, Russell SR et al. Automated analysis of retinal images for detection of referable diabetic retinopathy. JAMA Ophthalmol 2013; 131(3): 351-357.
32. Koreen S, Gelman R, Martinez-Perez ME, Jiang L, Berrocal AM, Hess DJ et al. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology 2007; 114(12): e59-e67.
33. Hewing NJ, Kaufman DR, Chan RV, Chiang MF. Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts. JAMA Ophthalmol 2013; 131(8): 1026-1032.
34. Ryan MC, Ostmo S, Jonas K, Berrocal A, Drenser K, Horowitz J et al. Development and evaluation of reference standards for image-based telemedicine diagnosis and clinical research studies in ophthalmology. AMIA Annu Symp Proc 2014; 2014: 1902-1910.
35. Ataer-Cansizoglu E, Kalpathy-Cramer J, You S, Keck K, Erdogmus D, Chiang MF. Analysis of underlying causes of inter-expert disagreement in retinopathy of prematurity diagnosis. Application of machine learning principles. Methods Inf Med 2015; 54(1): 93-102.
36. Kemper AR, Prosser LA, Wade KC, Repka MX, Ying GS, Baumritter A et al. A comparison of strategies for retinopathy of prematurity detection. Pediatrics 2016; 137(1): 1-10.
37. Campbell JP, Ataer-Cansizoglu E, Bolon-Canedo V, Bozkurt A, Erdogmus D, Kalpathy-Cramer J et al. Expert diagnosis of plus disease in retinopathy of prematurity from computer-based image analysis. JAMA Ophthalmol 2016; 134(6): 651-657.
38. Abbey AM, Besirli CG, Musch DC, Andrews CA, Capone Jr A, Drenser KA et al. Evaluation of screening for retinopathy of prematurity by ROPtool or a lay reader. Ophthalmology 2016; 123(2): 385-390.
39. Wilson CM, Cocker KD, Moseley MJ, Paterson C, Clay ST, Schulenburg WE et al. Computerized analysis of retinal vessel width and tortuosity in premature infants. Investig Ophthalmol Vis Sci 2008; 49(8): 3577-3585.
40. Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002; 120(11): 1470-1476.
41. Daniel E, Quinn GE, Hildebrand PL, Ells A, Hubbard GB 3rd, Capone A Jr et al. Validated system for centralized grading of retinopathy of prematurity: telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. JAMA Ophthalmol 2015; 133(6): 675-682.